B2M and breast cancer: The expression levels of β2M, HIF-1α, p-CREB, VEGF, p-SGK1, p-ERK1/2, and Bcl-2 were significantly higher in cancer tissues of patients with luminal A breast cancer compared to adjacent tissues (p < 0.05; Fig. 4a and Table 4).